Appears to have changed from "Active, Not Recruiting" to "Recruiting" on 3/13. Do I hear LeGrande gnashing his teeth?
I'm sure we'll see something positive. Thoughts?
"Only 5 in 5,000 drugs that enter preclinical testing progress to human testing. One of these 5 drugs that are tested in people is approved." So it's one in 5 if it gets to human testing.
Considering it could double their survival time? A resounding YES!
I have held both stocks for some time. I know others here have, also. They're going after some of the same indications but there's room for both. INO has made some excellent progress in the last year or so and is ready to enter it's first PIII for cervical dysplasia. They also have the same kind of fervent bashers we have. Ultimately, I think they will both succeed. INO's MC was about 665.18 million the other day and I think we'll be soon there also. There had been some bad blood between the two boards for a while but that seems to have dissipated. Of course, the choice falls to you but I have no intention of selling either right now.
Someone at Advaxis really needs to go over the clinical trials on the dot gov and update information. Is there really only one site up and running for prostate cancer?
Go to the Morningstar site and click on the "Ownership" tab for ADXS. It does look they increased in several funds as reported for 2/29.
Looking back, I could have made a fortune day trading but the uncertainty of when news would come always held me back. In the end, if all goes well, I think I'll be happy I held.